Aptamers Market Report 2026

Aptamers Market Overview

• Aptamers market size has reached to $3.25 billion in 2025 • Expected to grow to $9.84 billion in 2030 at a compound annual growth rate (CAGR) of 24.8% • Growth Driver: Growing Prevalence Of Chronic Respiratory Diseases Boosts Aptamers Market • Market Trend: Innovative Reagent To Address Challenges In The Immunohistochemistry (IHC) Market • North America was the largest region in 2025.

What Is Covered Under Aptamers Market?

Aptamers are short synthetic single-stranded oligonucleotides that fold into defined architectures and bind to target antigens such as proteins, molecules, peptides, cells, and tissues. It is used for the molecular recognition of their respective targets. The various types of aptamers are DNA aptamers, XNA aptamers, and RNA aptamers. DNA aptamers refer to deoxyribonucleic acid (DNA) oligonucleotides that are capable of binding to specific targets with high affinity and specificity to target antigens such as peptides, small molecules, cells, proteins, and tissues. It is used in the design of drug delivery systems. The various types of technology include selex, x-aptamer, and maras technique, which are applied in therapeutic development, research and development, diagnostics, and others. The different end users include pharmaceutical and biotechnology companies, academic and government research institutes, cathode-ray oscilloscopes, and others.

What Is The Aptamers Market Growth Forecast?

The aptamers market size is expected to see exponential growth in the next few years. It will grow to $9.84 billion in 2030 at a compound annual growth rate (CAGR) of 24.8%. The growth in the forecast period can be attributed to increasing adoption of aptamer-based diagnostics, technological integration with AI and biosensing platforms, growth in personalized medicine, rising collaborations between pharma and biotech companies, expansion in emerging markets for research and healthcare. Major trends in the forecast period include advanced targeted drug development, high-throughput screening techniques, customizable aptamer design, integration with biosensors and diagnostics, therapeutic and diagnostic market expansion.

Global Aptamers Market Segmentation

1) By Type: DNA Aptamers, XNA Aptamers, RNA Aptamers 2) By Technology: SELEX, X Aptamer, Maras Technique 3) By Application: Therapeutics Development, Research and Development, Diagnostic, Other Applications Subsegments: 1) By DNA Aptamers: Single-Stranded DNA (ssDNA) Aptamers, Double-Stranded DNA (dsDNA) Aptamers 2) By XNA Aptamers: Peptide Nucleic Acid (PNA) Aptamers, Locked Nucleic Acid (LNA) Aptamers, Glycyl Nucleic Acid (GNA) Aptamers 3) By RNA Aptamers: Small Interfering RNA (siRNA) Aptamers, Short Hairpin RNA (shRNA) Aptamers, Long Non-Coding RNA (lncRNA) Aptamers

What Is The Driver Of The Aptamers Market?

The increasing prevalence of chronic respiratory diseases is expected to propel the growth of the aptamers market going forward. Chronic respiratory disease is when the airways narrow and swell and may produce extra mucus. It makes breathing challenging and causes coughing, shortness of breath, and wheezing when exhaling. Aptamers help detect the respiratory syncytial virus (RSV), help identify disease early, and provide treatment. For instance, in June 2024, according to the Australian Institute of Health and Welfare, COPD accounted for 3.6% of the total disease burden and 50% of the disease burden related to respiratory conditions in 2023. Therefore, the rising prevalence of chronic respiratory diseases is driving the growth of the aptamers industry.

Key Players In The Global Aptamers Market

Major companies operating in the aptamers market are Aptamer Group Limited, SomaLogic Inc., Aptamer Sciences Inc., Aptagen LLC, NeoVentures Biotechnology Inc., Aptus Biotech, Base Pair Biotechnologies Inc., AMS Biotechnology Ltd., Vivonics Inc., TriLink Biotechnologies LLC, Noxxon Pharma SE, AM Biotechnologies LLC, Raptamer Discovery Group, Kaneka Corporation, Novaptech Inc., Maravai Lifesciences Inc., Bio-Techne Corporation, Creative Biolabs Inc., IBA Lifesciences GmbH, Aptabharat Innovations Pvt. Ltd., Profacgen Biotech Inc., Medi GmbH & Co. KG, Pure Biologics Sp. z o.o., Oak BioSciences Inc., Ophthotech Corporation, Novartis AG, NeoNeuro SAS, CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca PLC, GlyTech Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies Inc., IVERIC bio Inc.

Global Aptamers Market Trends and Insights

Major companies operating in the aptamers market are launching innovative reagents such as Optimer-Fc to address challenges in the immunohistochemistry (IHC) market. Optimer-Fc is a novel reagent used to automate immunohistochemistry (IHC) workflows. For instance, in March 2023, Aptamer Group PLC, a UK-based biotech company, launched Optimer-Fc, a novel reagent for automated immunohistochemistry (IHC) workflows, addressing challenges in the IHC market. The company collaborates with leading IHC firms, validates Optimer-Fc's performance, and negotiates trials with top pharmaceutical companies. Optimer-Fc, an antibody alternative, integrates Optimer binders into existing workflows, offering increased accuracy and selectivity for disease biomarkers in IHC applications. This innovation is crucial amid patent expirations for IHC antibodies, providing a patentable solution.

What Are Latest Mergers And Acquisitions In The Aptamers Market?

In June 2025, Illumina, a US-based genomics and sequencing company, acquired SomaLogic for US$ 350 million in cash, with an additional up to US$ 75 million in performance-based milestones. Through this acquisition, Illumina aims to advance its multi-omics strategy by integrating SomaLogic’s aptamer-based proteomics platform (SomaScan) and expanding its capabilities in high-throughput protein biomarker discovery. SomaLogic is a US-based company that provides aptamer-based proteomic solutions using SOMAmers to quantify thousands of proteins from biological samples.

Regional Insights

North America was the largest region in the aptamers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Aptamers Market?

The aptamers market includes revenues earned by entities by providing RNA profiling and detecting cells, viruses, sugars, and antibodies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Aptamers Market Report 2026?

The aptamers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the aptamers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.